|
SMC3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.443210E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.01969999999996E-05 |
| Normal-vs-Stage2 |
4.436400E-03 |
| Normal-vs-Stage3 |
2.532600E-01 |
| Normal-vs-Stage4 |
4.604200E-01 |
| Stage1-vs-Stage2 |
8.376600E-01 |
| Stage1-vs-Stage3 |
7.045500E-02 |
| Stage1-vs-Stage4 |
2.500400E-01 |
| Stage2-vs-Stage3 |
1.899010E-01 |
| Stage2-vs-Stage4 |
3.125600E-01 |
| Stage3-vs-Stage4 |
9.882400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.000070E-04 |
| Normal-vs-AfricanAmerican |
4.700500E-03 |
| Normal-vs-Asian |
3.858000E-01 |
| Caucasian-vs-AfricanAmerican |
6.977000E-01 |
| Caucasian-vs-Asian |
7.803200E-01 |
| AfricanAmerican-vs-Asian |
8.794800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.0839000003956E-07 |
| Normal-vs-Female |
9.070400E-01 |
| Male-vs-Female |
1.61344999999313E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.916850E-03 |
| Normal-vs-Extreme_Weight |
1.25419999996712E-06 |
| Normal-vs-Obese |
3.749700E-02 |
| Normal-vs-Extreme_Obese |
8.215800E-04 |
| Normal_Weight-vs-Extreme_Weight |
3.638200E-01 |
| Normal_Weight-vs-Obese |
2.036400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.075200E-01 |
| Extreme_Weight-vs-Obese |
1.240010E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.698200E-01 |
| Obese-vs-Extreme_Obese |
1.437760E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.565400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.737960E-02 |
| Normal-vs-Age(61-80Yrs) |
5.97019999992732E-07 |
| Normal-vs-Age(81-100Yrs) |
7.173700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.698100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.785100E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.323600E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.683200E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.263010E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.019000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.56908999999761E-05 |
| Normal-VS-Type2 PRCC |
1.95485999999745E-05 |
| Normal-VS-KIRP CIMP |
3.233500E-04 |
| Normal-VS-Unclassified PRCC |
2.623600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.517000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.22609999947998E-07 |
| Type1 PRCC-VS-Unclassified PRCC |
5.676100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.00159999966354E-07 |
| Type2 PRCC-VS-Unclassified PRCC |
4.330300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.584800E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.14029999956855E-07 |
| Normal-vs-N1 |
2.907200E-01 |
| Normal-vs-N2 |
9.167700E-02 |
| N0-vs-N1 |
1.26600000005528E-06 |
| N0-vs-N2 |
4.798600E-01 |
| N1-vs-N2 |
1.448970E-01 |
|
|
